Cargando…

High Level of Blood Eosinophils and Localization of Bronchiectasis in Patients with Severe Asthma: A Pilot Study

Background. Severe asthma and bronchiectasis are heterogeneous diseases that frequently coexist. The location of bronchiectasis is generally determined by specific underlying pathophysiological mechanisms. The aim of this study was to determine whether in a population suffering from both severe asth...

Descripción completa

Detalles Bibliográficos
Autores principales:	Quaranta, Vitaliano Nicola, Dragonieri, Silvano, Vulpi, Maria Rosaria, Crimi, Nunzio, Crimi, Claudia, Santus, Pierachille, Menzella, Francesco, Pelaia, Corrado, Scioscia, Giulia, Caruso, Cristiano, Bargagli, Elena, Scichilone, Nicola, Carpagnano, Giovanna Elisiana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9821283/ https://www.ncbi.nlm.nih.gov/pubmed/36615179 http://dx.doi.org/10.3390/jcm12010380

Ejemplares similares

Can Leukotriene Receptor Antagonist Therapy Improve the Control of Patients with Severe Asthma on Biological Therapy and Coexisting Bronchiectasis? A Pilot Study
por: Quaranta, Vitaliano Nicola, et al.
Publicado: (2022)

Benralizumab Effectiveness in Severe Eosinophilic Asthma with Co-Presence of Bronchiectasis: A Real-World Multicentre Observational Study
por: Campisi, Raffaele, et al.
Publicado: (2023)

Clinical and economic consequences of switching from omalizumab to mepolizumab in uncontrolled severe eosinophilic asthma
por: Carpagnano, Giovanna Elisiana, et al.
Publicado: (2021)

Real-world characteristics of “super-responders” to mepolizumab and benralizumab in severe eosinophilic asthma and eosinophilic granulomatosis with polyangiitis
por: Portacci, Andrea, et al.
Publicado: (2023)

Therapeutic Effects of Benralizumab Assessed in Patients with Severe Eosinophilic Asthma: Real-Life Evaluation Correlated with Allergic and Non-Allergic Phenotype Expression
por: Pelaia, Corrado, et al.
Publicado: (2021)

Effectiveness and safety of anti-IL-5/Rα biologics in eosinophilic granulomatosis with polyangiitis: a two-year multicenter observational study
por: Nolasco, Santi, et al.
Publicado: (2023)

Assessment of Five Questionnaires for Chronic Obstructive Pulmonary Disease in a Southern Italian Population: A Proof-of-Concept Study
por: Dragonieri, Silvano, et al.
Publicado: (2023)

Benralizumab in Patients with Severe Eosinophilic Asthma: A Multicentre Real-Life Experience
por: Scioscia, Giulia, et al.
Publicado: (2023)

Switching from omalizumab to mepolizumab: real-life experience from Southern Italy
por: Carpagnano, Giovanna Elisiana, et al.
Publicado: (2020)

Switch from Omalizumab to Benralizumab in Allergic Patients with Severe Eosinophilic Asthma: A Real-Life Experience from Southern Italy
por: Pelaia, Corrado, et al.
Publicado: (2021)

Effectiveness of benralizumab in severe eosinophilic asthma: Distinct sub‐phenotypes of response identified by cluster analysis
por: Di Bona, Danilo, et al.
Publicado: (2021)

Effects of benralizumab in a population of patients affected by severe eosinophilic asthma and chronic rhinosinusitis with nasal polyps: a real-life study
por: Santomasi, Carla, et al.
Publicado: (2023)

Breathing Rhythm Variations during Wash-In Do Not Influence Exhaled Volatile Organic Compound Profile Analyzed by an Electronic Nose
por: Dragonieri, Silvano, et al.
Publicado: (2021)

The Role of a Polymer-Based E-Nose in the Detection of Head and Neck Cancer from Exhaled Breath
por: Anzivino, Roberta, et al.
Publicado: (2022)

Short-Term Effect of Cigarette Smoke on Exhaled Volatile Organic Compounds Profile Analyzed by an Electronic Nose
por: Dragonieri, Silvano, et al.
Publicado: (2022)

Real-life effectiveness of mepolizumab in patients with severe refractory eosinophilic asthma and multiple comorbidities
por: Crimi, Claudia, et al.
Publicado: (2020)

Effect of Food Intake on Exhaled Volatile Organic Compounds Profile Analyzed by an Electronic Nose
por: Dragonieri, Silvano, et al.
Publicado: (2023)

Type 2-High Severe Asthma with and without Bronchiectasis: A Prospective Observational Multicentre Study
por: Crimi, Claudia, et al.
Publicado: (2021)

Real-life effects of dupilumab in patients with severe type 2 asthma, according to atopic trait and presence of chronic rhinosinusitis with nasal polyps
por: Pelaia, Corrado, et al.
Publicado: (2023)

The impact of healthcare setting on post-COVID mood disorders: a single-centre perspective from Southern Italy Respiratory Intensive Care Unit
por: Portacci, Andrea, et al.
Publicado: (2022)

The Predictors of Long COVID in Southeastern Italy
por: Quaranta, Vitaliano Nicola, et al.
Publicado: (2023)

The role of education in the self-compilation of asthma control test score in patients with asthma
por: Dragonieri, Silvano, et al.
Publicado: (2022)

Asthma and Fixed Airways Obstruction: Real Life Aspects
por: Buonamico, Enrico, et al.
Publicado: (2023)

Effects of anti‐IL5 biological treatments on blood IgE levels in severe asthmatic patients: A real‐life multicentre study (BIONIGE)
por: Contoli, Marco, et al.
Publicado: (2022)

Biological therapy for severe asthma
por: Dragonieri, Silvano, et al.
Publicado: (2021)

Early management of COPD: where are we now and where do we go from here? A Delphi consensus project
por: Di Marco, Fabiano, et al.
Publicado: (2019)

Adherence to omalizumab: A multicenter "real-world" study
por: Campisi, Raffaele, et al.
Publicado: (2020)

S-Adenosylmethionine May Mitigate Obstructive Sleep Apnea in an Adult with Down Syndrome: A Case Report
por: Dragonieri, Silvano, et al.
Publicado: (2022)

Switching Biological Therapies in Severe Asthma
por: Scioscia, Giulia, et al.
Publicado: (2023)

Case Report: Acute effect of benralizumab on asthma exacerbation without concomitant corticosteroid use
por: Nolasco, Santi, et al.
Publicado: (2020)

Effects of the first three doses of benralizumab on symptom control, lung function, blood eosinophils, oral corticosteroid intake, and nasal polyps in a patient with severe allergic asthma
por: Pelaia, Corrado, et al.
Publicado: (2020)

Real-World Experience with Dupilumab in Severe Asthma: One-Year Data from an Italian Named Patient Program
por: Campisi, Raffaele, et al.
Publicado: (2021)

Criteria of prescription of antibiotics and systemic corticosteroids among pulmonologists and general practictioners during asthma and COPD exacerbations: a southern Italian survey
por: Dragonieri, Silvano, et al.
Publicado: (2021)

Methodological Aspects of Induced Sputum
por: Dragonieri, Silvano, et al.
Publicado: (2023)

Exhaled volatile organic compounds for diagnosis and monitoring of asthma
por: Savito, Luisa, et al.
Publicado: (2023)

Body mass index, airflow obstruction, dyspnea, and exercise index is not modified after 6 months therapy with roflumilast in a cohort of patients with chronic obstructive pulmonary disease
por: Dragonieri, Silvano, et al.
Publicado: (2016)

Day and Night Control of COPD and Role of Pharmacotherapy: A Review
por: Braghiroli, Alberto, et al.
Publicado: (2020)

Influence of age and gender on the profile of exhaled volatile organic compounds analyzed by an electronic nose
por: Dragonieri, Silvano, et al.
Publicado: (2016)

Oxidative Stress and Respiratory System: Pharmacological and Clinical Reappraisal of N-Acetylcysteine
por: Santus, Pierachille, et al.
Publicado: (2014)

Short-Term Evaluation of Dupilumab Effects in Patients with Severe Asthma and Nasal Polyposis
por: Pelaia, Corrado, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_t4tdsu56lra6hj5dcde7i77jag